Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept for Myopic Choroidal Neovascularization
NCT02033018Phase 4Unknown
- Sponsor
- Instituto de Olhos de Goiânia
- Start
- Oct 2013
- Primary completion
- Nov 2014
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of aflibercept in choroidal neovascularization (CNV), sponsored by Instituto de Olhos de Goiânia. Status: unknown.
02
Drugs
aflibercept
03
Conditions
choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT02033018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033018.